Karmanos Cancer Institute recognized March as Multiple Myeloma Awareness Month

Karmanos Cancer Institute recognized March as Multiple Myeloma Awareness Month

DETROIT — The Barbara Ann Karmanos Cancer Institute cancer centers and other organizations nationwide recognized March as Multiple Myeloma Awareness Month. Multiple myeloma is a type of blood and bone marrow cancer, specifically targeting plasma cells, the cells responsible for producing antibodies. There is no cure for multiple myeloma, but there have been improvements in treatments with advances made by Karmanos physicians and researchers, acc…

Myeloma Specialist Seeks Improved Patient Outcomes From ‘Explosion’ of New Treatments

Hematologist-oncologist Mateo Mejia Saldarriaga, MD, combines clinical care with research aimed at helping patients with treatment-resistant multiple myeloma. Medscape Medical News

Heidelberg – When cancer cells in multiple myeloma break out of the bone and begin to multiply outside the bone marrow, a wide variety of tumor cells develops, accompanied by a significantly altered immune response. This is reported by a research team from the Heidelberg Medical Faculty and the German Cancer Research Center...